Sex‐specific effects of adiponectin on carotid intima‐media thickness and incident cardiovascular disease

Persson, J. et al. (2015) Sex‐specific effects of adiponectin on carotid intima‐media thickness and incident cardiovascular disease. Journal of the American Heart Association, 4(8), e001853. (doi:10.1161/JAHA.115.001853) (PMID:26276317) (PMCID:PMC4599454)

[img]
Preview
Text
140935.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

1MB

Abstract

Background: Plasma adiponectin levels have previously been inversely associated with carotid intima‐media thickness (IMT), a marker of subclinical atherosclerosis. In this study, we used a sex‐stratified Mendelian randomization approach to investigate whether adiponectin has a causal protective influence on IMT. Methods and Results: Baseline plasma adiponectin concentration was tested for association with baseline IMT, IMT progression over 30 months, and occurrence of cardiovascular events within 3 years in 3430 participants (women, n=1777; men, n=1653) with high cardiovascular risk but no prevalent disease. Plasma adiponectin levels were inversely associated with baseline mean bifurcation IMT after adjustment for established risk factors (β=−0.018, P<0.001) in men but not in women (β=−0.006, P=0.185; P for interaction=0.061). Adiponectin levels were inversely associated with progression of mean common carotid IMT in men (β=−0.0022, P=0.047), whereas no association was seen in women (0.0007, P=0.475; P for interaction=0.018). Moreover, we observed that adiponectin levels were inversely associated with coronary events in women (hazard ratio 0.57, 95% CI 0.37 to 0.87) but not in men (hazard ratio 0.82, 95% CI 0.54 to 1.25). A gene score of adiponectin‐raising alleles in 6 loci, reported recently in a large multi‐ethnic meta‐analysis, was inversely associated with baseline mean bifurcation IMT in men (β=−0.0008, P=0.004) but not in women (β=−0.0003, P=0.522; P for interaction=0.007). Conclusions: This report provides some evidence for adiponectin protecting against atherosclerosis, with effects being confined to men; however, compared with established cardiovascular risk factors, the effect of plasma adiponectin was modest. Further investigation involving mechanistic studies is warranted.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Strawbridge, Dr Rona
Authors: Persson, J., Strawbridge, R. J., McLeod, O., Gertow, K., Silveira, A., Baldassarre, D., Van Zuydam, N., Shah, S., Fava, C., Gustafsson, S., Veglia, F., Sennblad, B., Larsson, M., Sabater‐Lleal, M., Leander, K., Gigante, B., Tabak, A., Kivimaki, M., Kauhanen, J., Rauramaa, R., Smit, A. J., Mannarino, E., Giral, P., Humphries, S. E., Tremoli, E., de Faire, U., Lind, L., Ingelsson, E., Hedblad, B., Melander, O., Kumari, M., Hingorani, A., Morris, A. D., Palmer, C. N. A., Lundman, P., Öhrvik, J., Söderberg, S., and Hamsten, A.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Mental Health and Wellbeing
Journal Name:Journal of the American Heart Association
Publisher:American Heart Association, Inc.
ISSN:2047-9980
ISSN (Online):2047-9980
Published Online:14 August 2015
Copyright Holders:Copyright © 2015 The Authors
First Published:First published in Journal of the American Heart Association 4(8):e001853
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record